Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without CirrhosisKris V. Kowdley, Michael Fried, Robert Herring et al.|New England Journal of Medicine|2014Cited by 1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment OptionsIra M. Jacobson, David R. Nelson, Stuart C. Gordon et al.|New England Journal of Medicine|2013Cited by 1.1k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Atif Zaman, Gregory T. Everson et al.|Gastroenterology|2015Cited by 799
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV InfectionMarc Bourlière, Stefan Zeuzem, Stuart C. Gordon et al.|New England Journal of Medicine|2017Cited by 565
Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis BJay H. Lefkowitch, Roger Vaughan, Eugene R. Schiff et al.|Gastroenterology|1993Cited by 374